IFNα-2a and IFNα-2b are used to treat chronic hepatitis B or C, as well as various neoplasms [18,19], while IFNβ-1a and IFNβ-1b are employed in the therapy of multiple sclerosis [20]. This evidence concerns the gene IFNA2 and multiple sclerosis.